Clinical Oncology
Volume 16, Issue 8 , Pages 575-576, December 2004

Neutropenia occurring after starting gabapentin for neuropathic pain

  • E. Derbyshire

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: Dr Emma Derbyshire, GP Registrar to Dr K. Finlay, Rusthall Medical Centre, Nellington Road, Tunbridge Wells, Kent TN4 8UW. Tel: +44-1892-515779; Fax: +44-1892-532256.
    • ,
  • D. Martin

Rusthall Medical Centre, Nellington Road, Tunbridge Wells, Kent TN4 8UW, UK

Received 7 May 2004; received in revised form 21 June 2004; accepted 22 June 2004.

Abstract 

We report a case of neutropenia occurring in a patient receiving gabapentin for neuropathic pain. Five weeks after treatment started, the patient was admitted to hospital with neutropenic sepsis. Gabapentin is widely used, and neutropenia is a rare adverse effect. This case highlights a serious and potential life-threatening complication.

Key words: Gabapentin, neuropathic pain, neutropenia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0936-6555(04)00242-0

doi:10.1016/j.clon.2004.06.015

Clinical Oncology
Volume 16, Issue 8 , Pages 575-576, December 2004

Article Tools